Apyx Medical CorporationSEC Filings
|
|
All SEC filings by Apyx Medical Corporation (APYX) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 6, 2026 | |
| 10-Q | Quarterly report | View Diff | May 7, 2026 | |
| 10-K | Annual report | View Diff | Mar 10, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 6, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 7, 2025 | |
| 10-Q | Quarterly report | View Diff | May 8, 2025 | |
| 10-K | Annual report | View Diff | Mar 13, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 8, 2024 | |
| 10-Q | Quarterly report | View Diff | Aug 8, 2024 | |
| 10-Q | Quarterly report | View Diff | May 9, 2024 |
Events
| 8-K | Current report | Aug 7, 2026 | ||
| 8-K | Apyx Medical Corporation Reports 2026 Financial Results Clearwater, Fl | Aug 6, 2026 | ||
| 8-K | Current report | Jul 24, 2026 | ||
| 8-K | Current report | Jun 17, 2026 | ||
| 8-K | Other Events | May 21, 2026 | ||
| 8-K | Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction | May 14, 2026 | ||
| 8-K | Addition of the Power Liposuction Capability as a Second Advanced Liposuction Modality Is Expected to Drive Even Greater Market Demand for Ayon | May 11, 2026 | ||
| 8-K | Apyx Medical Corporation Reports First Quarter 2026 Financial Results | May 7, 2026 | ||
| 8-K | Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results | Mar 10, 2026 | ||
| 8-K | Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results | Jan 12, 2026 |
Registrations and Prospectuses
| S-3 | Shelf registration | View Diff | Dec 1, 2025 | |
| 424B5 | Prospectus supplement for primary offering | Nov 18, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | Nov 17, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | Nov 8, 2024 | ||
| S-8 | Registration of securities for employees | Nov 16, 2023 | ||
| S-8 | Registration of securities for employees | Nov 16, 2023 | ||
| S-3/A | Shelf registration | View Diff | Dec 2, 2022 | |
| S-3 | Shelf registration | Nov 22, 2022 | ||
| S-8 | Registration of securities for employees | Aug 18, 2021 | ||
| S-8 | Registration of securities for employees | Sep 28, 2019 |
Proxies
| DEF 14A | Definitive proxy | View Diff | Jun 26, 2026 | |
| DEF 14A | Definitive proxy | View Diff | Jun 25, 2025 | |
| PRE 14A | Preliminary proxy | Jun 13, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Jun 25, 2024 | |
| DEF 14A | Definitive proxy | View Diff | Jun 23, 2023 | |
| DEF 14A | Definitive proxy | View Diff | Jun 24, 2022 | |
| DEFA14A | Additional proxy soliciting materials | Jul 6, 2021 | ||
| DEF 14A | Definitive proxy | View Diff | Jun 25, 2021 | |
| DEFA14A | Additional proxy soliciting materials | Jun 30, 2020 | ||
| DEF 14A | Definitive proxy | View Diff | Jun 26, 2020 |
Other
| SD | Conflict minerals disclosure | Jun 1, 2026 | ||
| EFFECT | Notice of effectiveness | Dec 17, 2025 | ||
| SD | Conflict minerals disclosure | May 30, 2025 | ||
| SD | Conflict minerals disclosure | May 31, 2024 | ||
| SD | Conflict minerals disclosure | May 31, 2023 | ||
| EFFECT | Notice of effectiveness | Dec 5, 2022 | ||
| UPLOAD | Letter from SEC | Nov 30, 2022 | ||
| CORRESP | Correspondence with SEC | Nov 30, 2022 | ||
| SD | Conflict minerals disclosure | May 27, 2022 | ||
| SD | Conflict minerals disclosure | May 26, 2021 |
Ownership
| SC 13G/A | Beneficial ownership report | Jul 21, 2026 | ||
| 4 | Waldman Lawrence | Jul 2, 2026 | ||
| 4 | Roman Shawn David | Jun 17, 2026 | ||
| 4 | Levine Wendy Lauren | Jun 15, 2026 | ||
| 4 | Vizirgianakis Stavros G. | Jun 15, 2026 | ||
| 4 | Goodwin Charles D. Ii | Jun 15, 2026 | ||
| 4 | Roman Shawn David | Jun 15, 2026 | ||
| 4 | Baylor-Henry Minnie | Jun 15, 2026 | ||
| 4 | Waldman Lawrence | Jun 15, 2026 | ||
| 4 | Hill Matthew C | Jun 15, 2026 |